ABBVIE SDN BHD

ABBVIE SDN BHD Company Introduction

ABBVIE SDN BHD is the Malaysian subsidiary of AbbVie Inc., a global biopharmaceutical company. It is dedicated to the discovery, development, manufacturing, and commercialization of innovative medicines.

The company's focus areas include immunology, oncology, neuroscience, virology, eye care, and women's health. In Malaysia, ABBVIE SDN BHD is responsible for the sales, marketing, distribution, and potentially clinical operations of AbbVie's pharmaceutical products.

Factory or Trader

ABBVIE SDN BHD operates primarily as a **trader** and a **commercial entity** in Malaysia. It is responsible for the importation, sales, marketing, and distribution of pharmaceutical products manufactured by AbbVie's global manufacturing sites. It is not a manufacturing plant or factory for primary drug production within Malaysia.

Here are some products manufactured or marketed by ABBVIE SDN BHD in Malaysia:

* Humira (adalimumab)

* Mavyret (glecaprevir/pibrentasvir)

* Skyrizi (risankizumab)

* Venclyxto (venetoclax)

* Duodopa (levodopa/carbidopa)

* Botox (onabotulinumtoxinA)

* Imbruvica (ibrutinib)